• Explore /
  • Poster
  • / Phase 2 multi-institutional prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged 80 years or more after curative resection of colorectal cancer: The HiSCO-03 study.

Phase 2 multi-institutional prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged 80 years or more after curative resection of colorectal cancer: The HiSCO-03 study.

Abstract Video & Slides Poster

Authors

null

Masashi Miguchi Sr.

Hiroshima Prefectural Hospital, Hiroshima, Japan;

Masashi Miguchi Sr., Satoshi Ikeda , Manabu Shimomura Sr., Masahiro Nakahara , Tomohiro Adachi , Yasuyo Ishizaki , Yasufumi Saitoh , Kazuhiro Toyota , Daisuke Sumitani , Yosuke Shimizu , Yuji Takakura , Wataru Shimizu , Masanori Yoshimitsu , Shinya Kodama , Masahiko Fujimori , Mamoru Oeda , Hironori Kobayashi , Hideki Ohdan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

R000013902

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 101)

DOI

10.1200/JCO.2023.41.4_suppl.101

Abstract #

101

Poster Bd #

E18

Abstract Disclosures

Similar Posters

First Author: Manabu Shimomura Sr.

First Author: Maryam B. Lustberg

First Author: Per Pfeiffer

First Author: In Gyu Hwang